Brief: AnaptysBio Q3 Net Income USD 15.113 Million
04/11/2025 21:15
Nov 04 (Reuters) - AnaptysBio Q3 collaboration revenue USD 76.32 million. Q3 operating expenses USD 41.616 million Q3 income from operations USD 34.704 million
Recent news on AnaptysBio
See all newsU.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
AnaptysBio's Q1 collaboration revenue falls, net loss widens
Brief: AnaptysBio Q1 Net Income USD -52.884 Million
Brief: Anaptys Appoints Chris Murphy As Chief Financial Officer And Owen Hughes To Board Of Directors
Brief: GSK Says Unit Tesaro's Claim For Declaratory Judgment Against Anaptysbio Unchanged